Maternal-fetal prognosis in HELLP syndrome in a level 3 maternal-fetal care centre

• Published in: Clinical and experimental obstetrics & gynecology Vol. 43; no. 3; pp. 374 - 378
• Main Authors: SocolIov, D, Ilea, C, Lupascu, I Anghelache, Blidaru, I, Luca, A, Radescu, M, Carauleanu, A, Socolov, R
• Format: Journal Article
• Language: English
• Published: Canada 01-01-2016
• Subjects: Abruptio Placentae - epidemiology; Adult; Birth Weight; Disseminated Intravascular Coagulation - epidemiology; Eclampsia - epidemiology; Female; Fetal Death; Fetal Growth Retardation - epidemiology; Fetus; HELLP Syndrome - epidemiology; HELLP Syndrome - mortality; Humans; Infant, Newborn; Male; Maternal Death; Pre-Eclampsia - epidemiology; Pregnancy; Pregnancy Outcome; Premature Birth - epidemiology; Prognosis; Respiratory Distress Syndrome, Newborn - epidemiology; Retrospective Studies; Tertiary Care Centers; Young Adult
• ISSN: 0390-6663
• DOI: 10.12891/ceog3111.2016

The purpose of this study was to evaluate the maternal and perinatal outcome and prognosis in pregnant women with HELLP syndrome.
Medical records of eligible pregnant women with HELLP syndrome were reviewed retrospectively. Patients were evaluated in terms of maternal complication, as well as the types of delivery. Perinatal outcome were evaluated in terms ofApgar score, birth weight, respiratory distress syndrome, and neonatal intensive care unit admission.
The leading maternal complications associated with HELLP syndrome were the following: severe preeclampsia, eclampsia, placental abruption, acute pulmonary edema, acute kidney failure, disseminated intravascular coagulation syndrome, and immediate maternal death. The most prominent neonatal outcomes associated with HELLP syndrome were: antenatal fetal death, intrauterine growth restriction, prematurity.
The management and delivery of the patients with HELLP syndrome must take place in a tertiary referral maternal and fetal care centre.